You are here

Home » Content

DEMİR EKSİKLİĞİ ANEMİSİ VE DEMİR TEDAVİSİNİN PLAZMA TİROİD HORMON DÜZEYLERİNE ETKİSİ

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The effect of iron-deficiency anemia and iron treatment on plasma thyroid hormone levels. To determine of possible alterations in plasma triiodothyroinine (T3) and thyroxine (T4) levels in patients with iron deficiency anemia (IDA) Subjects and Method: Thirty women (mean age 37,9+1,9 yr) with IDA and euthyroid clinic and 26 controls (mean age 34,7±1,4 yr) were enrolled in this study. Hemoglobin, hematocrite, serum iron, serum iron binding capacity, ferritin, T3, T4, and thyrotropin (TSH) measurements were performed in both gıoups at basal state and repeated after oral iron supplementation of three months in IDA group. At basal state T3 and T4 levels of IDA group were significantly lower than controls (4,7+0,2 vs. 5,3+0,1 pmol/1 and 14,3+0,5 vs. 16,5+0,2 pmol/1; p=0,009 and p<0,001, respectively). The mean TSH levels of IDA group was not different from controls (p>0,05). After iron supplementation there were significant increase in T3 (5,4(0,3 pmol/1; p=0,022) and T4 (16,1+0,8 pmol/1; p=0,037) and decrease in TSH (2,5+0,4 vs. 1,7+0,3 ulU/ml; p=0,009) when compaıed with basal levels. The differences between IDA group and controls with respect to thyroid hormone levels were disappeared after iron supplementation. We propose that IDA and iron supplementation have a significant role on thyroid hormon levels.
Bookmark/Search this post with
Abstract (Original Language): 
Demir eksikliği anemisi (DEA) olan hastalarda plazma triiodotironin (T3) ve tiroksin (T4) düzeylerinde bir değişikliğin olup olmadığını saptamaktır. Hastalar ve Yöntem: Bu çalışmaya DEA ve ötiroid kliniği olan 30 kadın (ortalama yaş 37,9+1,9 yıl) ve 26 kontrol (ortalama yaş 34,7+1,4 yıl) alındı. Hemoglobin, hematokrit, serum demir, serum demir bağlama kapasitesi, ferritin, T3, T4 ve tirotropin (TSH) ölçümleri bazal durumda her iki grupta ve üç aylık demir tedavisinden sonra da DEA olan grupta tekrarlandı. Bazal durumda, DEA olan grupta T3 ve T4 düzeyleri kontrollerden anlamlı olarak daha düşük saptandı (sırasıyla 4,7+0,2'ye karşılık 5,3+0,1 pmol/1 ve 14,3±0,5'e karşılık 16,5+0,2 pmol/1; p=0,009 ve p<0,001). TSH açısından anlamlı bir fark yoktu (p>0,05). Demir tedavisinden sonra bazal değerlere göre T3 (5,4+0,3 pmol/1; p=0,022) ve T4 (16,1+0,8 pmol/1; p=0,037) düzeylerinde anlamlı bir yükselme olurken TSH düzeylerinde anlamlı bir düşme oldu (2,5+0,4'ten 1,7±0,3 ulU/ml'ye; p=0,009). Tiroid hormonları açısından DEA grubu ile kontroller arasındaki farklar üç aylık demir tedavisinden sonra kayboldular. DEA'nin ve demir tedavisinin tiroid hormon düzeyleri üzerinde önemli bir rolünün olduğu görüşündeyiz.
FULL TEXT (PDF): 
PDF icon arastirmax-demir-eksikligi-anemisi-demir-tedavisinin-plazma-tiroid-hormon-duzeylerine-etkisi.pdf
  • 2
125-128
  • Turkish

REFERENCES

References: 

1. Beard J, Finch CA, Green WL: Interactions of iron deficiency, anemia, and (hyroid honnone levels in response of rats to cold exposure. Life Sci 30:691 (1982).
2. Beard J, Green W, Miller L, and Finch C: Effect of iron-deficiency anemia on hormone levels and Iheımoregula-tion during cold exposure. Am J Physiol 247:R114 (1984).
3. Beard JL, Borel MJ, and Derr J: Inıpaired thermoregula-tion and thyroid function in iron-deficiency anemia. Am JClin Nutr 52:813 (1990).
4. Beard JL, Brigham DE, Kelley SK, and Green MH: Plasma thyroid hormone kinetics are altered in iron-deficient rats. J Nutr 128:1401 (1998).
5. Beard J, Tobin B, and Green W: Evidence for thyroid hormone deficiency in iron-deficient anemic rats. J Nutr 119:772 (1989).
6. Cook JD, Lynch SR: The liabilities of iron deficiency. Blood 68:803(1986).
7. Dallman PR: Manifestations of iron deficiency. Semin Hematol 19:19(1982).
8. Dallman PR: Biochemical basis for the manifestations of iron deficiency. Ann Rev Nutr 6:13 (1986).
9. Demaeyer E, Adiels-Tegman M: Prevalence of anemia in the world. World health Stat Q 38:302 (1985).
10. Harris ARC, Fang SL, Azizi F, Lipvvorth L, Vagenakis AG and Braverman LE: Effect of starvation on hypotha-lamic-pituitary-thyroid function in the rat. Metabolisnı 127:1074(1978).
11. Lukaski HC, Hail CB and Nielsen FH: Theımogenesis and thermoregulatory function of iron-deficient women vvithout anemia. Aviat Space Environ Med 61:913 (1990).
12. Martinez-Torıes C, Cubeddu L, Dillmann E, Brengel-mann GL, Leets J, Layrisse M, Johnson DG, and Finch C: Effect of exposuıe to low tempeıature on normal and iron-deficient subjects. Am J Physiol 246:R380 (1984).
13. Silva JE and Larsen PR: Regulation of thyroid honnone expression at the prereceptor and receptor level. "Thyroid hormone metabolism, edilör: Marcel Dekker, Nevv York (1986)", sayfa: 441.
14. Zimmermann M, Adou P, Torresani T, Zeder C, and Hurrell R: Persistence of goiter despite oral iodine supplementation in goitrous children \vith iron deficiency anemia in Cote d'Ivoire. Am J Clin Nutr 71:88 (2000).

Thank you for copying data from http://www.arastirmax.com